Joana Chambel Coelho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joana Chambel Coelho has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Andreia Bento-Silva
Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal
1 shared publication Carlos Varela
Vetdental, Servicio Móvil de Odontología y Cirugía Oral, Galiza, Spain
1 shared publication- Lisa Alexandra Mestrinho
University of Lisbon, Avenida da Universidade Técnica, 1300-477 Lisbon, Portugal
1 shared publication Lisa Mestrinho
Faculdade de Medicina Veterinária, Universidade de Lisboa, Avenida da Universidade Técnica, Lisboa, Portugal
1 shared publication- Maria Rosário Bronze
BET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2781-901 Oeiras, Portugal
1 shared publication - Noélia Duarte
Med.ULisboa, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal
1 shared publication
Latest Publications
- 3 March 2025
- Published by SAGE Publications in Journal of Veterinary Dentistry
Longitudinal Evaluation of Permanent Dental Anomalies in a Group of Yorkshire Terriers Referred for Dental Consultation
Oral and dental diseases are among the most common problems observed in small-breed dogs. The Yorkshire Terrier is one of the breeds that most often exhibits oral disease at an early stage, namely, periodontal disease as well as persistent deciduous teeth. The present study aims to describe and analyze primary dental–skeletal anomalies in Yorkshire Terrier dogs aged <2 years, observed in referral dentistry practices, between 2015 and 2024. Dogs with full-mouth dental radiographs and charting were included. Dental agenesis, malocclusions and crowding, persistent deciduous teeth, and shape anomalies were the most frequent findings. Agenesis was mostly encountered in mandibular third molars (90% of dogs, 53 of 183 missing teeth) and was significantly associated with the presence of fused roots in the second molars ( P = .0006). Shape abnormalities included microdontia, dilaceration, and fused roots. The previously described bilateral carnassial tooth malformations were observed in 10% of individuals. Eruption anomalies were significantly associated with malocclusion ( P = .008). Although these results were based on a convenience sample referred for dental consultation and cannot be extrapolated for the overall population, they show a tendency, which can be a reflection of the dogs’ reduced size. Hypodontia and oligodontia in these breeds are possibly an advantage, which can decrease occurrence and severity of malocclusions.
- 3 March 2025
- Published by SAGE Publications in Journal of Veterinary Dentistry
Longitudinal Evaluation of Permanent Dental Anomalies in a Group of Yorkshire Terriers Referred for Dental Consultation
Oral and dental diseases are among the most common problems observed in small-breed dogs. The Yorkshire Terrier is one of the breeds that most often exhibits oral disease at an early stage, namely, periodontal disease as well as persistent deciduous teeth. The present study aims to describe and analyze primary dental–skeletal anomalies in Yorkshire Terrier dogs aged <2 years, observed in referral dentistry practices, between 2015 and 2024. Dogs with full-mouth dental radiographs and charting were included. Dental agenesis, malocclusions and crowding, persistent deciduous teeth, and shape anomalies were the most frequent findings. Agenesis was mostly encountered in mandibular third molars (90% of dogs, 53 of 183 missing teeth) and was significantly associated with the presence of fused roots in the second molars ( P = .0006). Shape abnormalities included microdontia, dilaceration, and fused roots. The previously described bilateral carnassial tooth malformations were observed in 10% of individuals. Eruption anomalies were significantly associated with malocclusion ( P = .008). Although these results were based on a convenience sample referred for dental consultation and cannot be extrapolated for the overall population, they show a tendency, which can be a reflection of the dogs’ reduced size. Hypodontia and oligodontia in these breeds are possibly an advantage, which can decrease occurrence and severity of malocclusions.
- Open Access
Placebo-Controlled Trial of Daily Oral Cannabidiol as Adjunctive Treatment for Cats with Chronic Gingivostomatitis
A placebo-controlled study evaluated the clinical efficacy and safety of a commercially available cannabidiol (CBD) oral formulation as an adjunctive treatment for pain management for feline chronic gingivostomatitis (FCGS). CBD was included in a multimodal treatment routinely performed on client-owned cats with FCGS that were submitted to dental extractions. Twenty-two cats were consecutively included in the study. The first group was treated using a fixed dosage of 4 mg per cat every 12 h for 15 consecutive days, and the second received a placebo of similar features. Treatments began 2 h before dental extractions. Pain and disease severity were assessed at days 0 and 15 using the Composite Oral Pain Scale (COPS-C/F) and the Stomatitis Disease Activity Index score (SDAI). Weight, vital and biochemistry parameters, and analgesic reinforcement needs were also registered at the same time points. In the treated cats, blood was collected after 4, 8, and 12 h to determine CBD serum concentrations using ultra-high-performance liquid chromatography–mass spectrometry (UHPLC-MS/MS). After data analysis using mixed models, a significant improvement in the SDAI scores of cats medicated with CBD was found. The protocol is safe since severe adverse effects and biochemical changes were not observed during the treatment period. This study suggests that the cats benefited from this treatment.
Open AccessPlacebo-Controlled Trial of Daily Oral Cannabidiol as Adjunctive Treatment for Cats with Chronic Gingivostomatitis
A placebo-controlled study evaluated the clinical efficacy and safety of a commercially available cannabidiol (CBD) oral formulation as an adjunctive treatment for pain management for feline chronic gingivostomatitis (FCGS). CBD was included in a multimodal treatment routinely performed on client-owned cats with FCGS that were submitted to dental extractions. Twenty-two cats were consecutively included in the study. The first group was treated using a fixed dosage of 4 mg per cat every 12 h for 15 consecutive days, and the second received a placebo of similar features. Treatments began 2 h before dental extractions. Pain and disease severity were assessed at days 0 and 15 using the Composite Oral Pain Scale (COPS-C/F) and the Stomatitis Disease Activity Index score (SDAI). Weight, vital and biochemistry parameters, and analgesic reinforcement needs were also registered at the same time points. In the treated cats, blood was collected after 4, 8, and 12 h to determine CBD serum concentrations using ultra-high-performance liquid chromatography–mass spectrometry (UHPLC-MS/MS). After data analysis using mixed models, a significant improvement in the SDAI scores of cats medicated with CBD was found. The protocol is safe since severe adverse effects and biochemical changes were not observed during the treatment period. This study suggests that the cats benefited from this treatment.